The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes - Wikidata - awgldk - TriplyDB

The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes

The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes

http://www.wikidata.org/entity/Q30828348

about

CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS.Localized-statistical quantification of human serum proteome associated with type 2 diabetes Examining the significance of fingerprint-based classifiers.Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene.Proteomic technologies for the discovery of type 1 diabetes biomarkers Identification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes.Human serum proteome analysis: new source of markers in metabolic disorders.Proteomic analysis of aqueous humor from patients with myopia.Transthyretin: the servant of many masters.Neuronatin: a new inflammation gene expressed on the aortic endothelium of diabetic mice.A simple and reliable protocol for mouse serum proteome profiling studies by use of two-dimensional electrophoresis and MALDI TOF/TOF mass spectrometry.Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion.A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.Proteomics as a tool to discover biomarkers for the prediction of diabetic complications.miR-223 contributes to the AGE-promoted apoptosis via down-regulating insulin-like growth factor 1 receptor in osteoblasts.Gender dimorphism in regulation of plasma proteins in streptozotocin-induced diabetic rats.Multiplex Biomarker Approaches in Type 2 Diabetes Mellitus Research.Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra A mitochondrial proteome profile indicative of type 2 diabetes mellitus in skeletal muscles

P2860

Q24644566-C1341507-E870-4343-A309-25FF7B6A7B10 Q30395380-50E103B9-F9CC-4B98-8FFF-8783EEC558F1 Q33369848-3D83DF28-D507-4C04-8B80-F2A80ADD3D1F Q33394036-A924F5F6-E49B-4FA3-A902-289E1077B0ED Q33507899-05CB4844-FB63-4751-A84A-8FAB7FD8457C Q33642475-850D74AB-DB8C-4D94-96B2-7F1E008FC149 Q34078908-99D2A429-EC21-40A6-8D80-C530429FEB69 Q34507490-42159CEF-E98D-48D7-819E-C6227E07FA69 Q36499341-74B1F71E-4FD2-47B5-909E-1BFCB4B93CEA Q36763960-36E0E9AC-8130-4FBB-A326-8A0320912B24 Q36906395-F0AD06D7-9FDE-4271-B0C8-B65AAFCB1200 Q36926647-D45CB16E-1CDE-463F-ADE3-2BF6340B0342 Q37320446-42CE74EF-2D54-4ED5-B201-C54A83197549 Q37623635-BE3D453B-4D8F-444F-95A4-5F4633204E5B Q38045278-378A45C5-DCF1-41B1-96F4-8CFA9292685E Q38089733-44CADEC1-AEB0-41F6-96DD-E1D9537B3AAD Q38792762-8EEAFFB0-5AA2-490F-AC22-CEE5F6AF9E76 Q50899001-FECAB2B0-30E2-4E0C-818A-BCA999046E11 Q51091532-7253856C-8AD2-4559-A3EA-941E807424A0 Q58201176-5D642B07-D63C-4A6C-B06D-C0148148BB5E Q59126279-7B650763-4D68-4DE0-BB5E-2DFE10690F0F

P2860

The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes

http://www.wikidata.org/entity/Q30828348

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

The use of proteomics in ident ...... in humans with type 2 diabetes

@ast

The use of proteomics in ident ...... in humans with type 2 diabetes

@en

type

label

The use of proteomics in ident ...... in humans with type 2 diabetes

@ast

The use of proteomics in ident ...... in humans with type 2 diabetes

@en

prefLabel

The use of proteomics in ident ...... in humans with type 2 diabetes

@ast

The use of proteomics in ident ...... in humans with type 2 diabetes

@en

P1433

Q30828348-286D431A-F9AD-4D6E-8CDD-649DC9FF1588

P1476

Q30828348-25A29D3A-1935-4EFD-9219-D885272DA473

P2093

Q30828348-04601218-FC66-4F38-901F-EA1F45300F76

Q30828348-179B3612-E600-4C71-A5ED-371977A06CD8

Q30828348-3B55DE8C-BF76-4A48-89F1-E1BA093920D4

Q30828348-E2FE6441-378D-4290-B41A-2897D35AF902

P2860

Q30828348-04229C03-37F2-4022-8271-F6F59FE762A8

Q30828348-0B6F38C2-161B-426A-895E-88B6E8C16313

Q30828348-18E04524-F3F3-4601-90ED-169E44A2BC10

Q30828348-198EABDD-C3D1-4AEA-B972-83D86A7EDE6B

Q30828348-1BBB38C5-290E-416A-B74C-1B71BB734294

Q30828348-1C74B0DB-05DD-439E-AFF8-54F585AA5E96

Q30828348-1D28300B-BCB6-473C-A610-534613EE8FE6

Q30828348-1FFD1D6D-DCEA-450F-9F5A-A297E63ACECA

Q30828348-2BD76E89-BF0B-44BB-A2CA-59560127C57E

Q30828348-2FB01D41-FE6B-4103-A823-5DF5846037D1

P2888

Q30828348-F36763FD-F0FC-4C3B-877A-BDB18814AAD1

P304

Q30828348-9A4D4F56-FC61-4EA3-8593-97BF79E37873

P31

Q30828348-67B5CA61-B8D9-4BB1-8EA0-84C1BA7ADEAB

P356

Q30828348-D0ADF0DC-A488-4317-AFC4-CC53D8F07AE3

P478

Q30828348-0632A661-A107-4B48-AE6A-7807905EEA51

P577

Q30828348-F7962F59-6398-45A4-B31D-57D24ACDBA5D

P5875

Q30828348-E3950166-8410-4D48-8CAB-68F2367567A2

P6179

Q30828348-187573B6-ACA5-4E13-B676-453D47EB35F1

P698

Q30828348-26A83DD7-F3B4-4B47-862D-62618851F7BF

P921

Q30828348-DBC3F123-2B78-4C31-902B-B8077D35DE2F

P932

Q30828348-5F9DBDDA-EBE2-4091-BFA1-CE4E50A49D53

P356

P1433

Proteome Science

P1476

The use of proteomics in ident ...... in humans with type 2 diabetes

@en

P2093

Michael Eberhardson

http://www.w3.org/2001/XMLSchema#string

Michael Göransson

http://www.w3.org/2001/XMLSchema#string

Peter Bergsten

http://www.w3.org/2001/XMLSchema#string

Tea Sundsten

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans

Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A

Acute-phase proteins and other systemic responses to inflammation

A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes.

Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

ProteinChip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease.

The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins.

Evaluation of an integrated strategy for proteomic profiling of skeletal muscle.

Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI ProteinChip platform.

P2888

P304

22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-5956-4-22

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6635840

http://www.w3.org/2001/XMLSchema#string

P6179

1014920465

http://www.w3.org/2001/XMLSchema#string

P698

17163994

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

1716156

http://www.w3.org/2001/XMLSchema#string